China Resources Double Crane and Real Biology signed a contract for the processing of Azvudine tablets, and the stock price has risen by more than 151% in the past two months.

Post date May 9, 2022 — 14:25 Post Lock

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Hualin Securities (002945): CITIC Securities Co., Ltd. Report on Interim Trustee Management Affairs of Hualin Securities Co., Ltd. on the Change of Directors- CFi.CN Zhongcai.com

May 20, 2022 — 17:56

CanSino’s new crown vaccine is recognized by the WHO. Why do brokerages still give the industry a cautious recommendation rating? New Coronary Pneumonia_Sina Finance_Sina.com

May 20, 2022 — 17:54

63 A-share chips changed hands (May 20) _ Oriental Fortune Net

May 20, 2022 — 17:50

Photovoltaic concept stocks have been sought after by 6.6 billion main funds in the past three days_Oriental Fortune Network

May 20, 2022 — 17:47

[Company Frontline] Leon Technology Adds "Tik Tok Concept"

May 20, 2022 — 17:43

Jinchen Co., Ltd. has added new achievements to its overseas strategy—the high-efficiency module production line of Risen Energy’s Malaysian base was successfully put into production

May 20, 2022 — 17:42

Asia Potash International: The company's projects can also enjoy the policy advantages of Laos as a member of ASEAN and a member of RCEP in terms of regional economic and trade environment, import and export and taxation.

May 20, 2022 — 17:41

CanSino’s new crown vaccine is recognized by the WHO. Why do brokerages still give the industry a cautious recommendation rating? CFi.CN

May 20, 2022 — 17:35

Zhongsheng Pharmaceutical was investigated by 13 institutions: Fufang Xueshuantong Capsule and Naoshuantong Capsule strengthened evidence-based evidence through medical research and obtained high-quality clinical research results (with survey questions and answers)

May 20, 2022 — 16:00

Home » News » China Resources Double Crane and Real Biology signed a contract for the processing of Azvudine tablets, and the stock price has risen by more than 151% in the past two months.